Early effects of human papillomavirus vaccination in Belgium

被引:11
作者
Merckx, Mireille [1 ,2 ]
Vanden Broeck, Davy [1 ]
Benoy, Ina [3 ]
Depuydt, Christophe [3 ]
Weyers, Steven [2 ]
Arbyn, Marc [4 ]
机构
[1] Univ Ghent, ICRH, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Dept Obstet & Gynaecol, Ghent, Belgium
[3] Son Hlth Care AML, Antwerp, Belgium
[4] Sci Inst Publ Hlth, Canc Epidemiol Unit, Brussels, Belgium
关键词
CROSS-PROTECTIVE EFFICACY; GRADE CERVICAL LESIONS; METAANALYSIS; PREVENTION; INFECTION; CANCER;
D O I
10.1097/CEJ.0000000000000067
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human papillomavirus (HPV) vaccination has been reimbursed in Belgium since 2007 for girls (12-15 years), extended to girls up to 18 years in 2008. This study assesses the trend of HPV 16/18 infections in women less than 25 years of age participating in opportunistic cervical cancer screening. A significant reduction in the prevalence of HPV 16 [relative risk (RR)=0.61, 95% confidence interval=0.39-0.95] and a nonsignificant reduction in HPV 18 (RR=0.65, 95% confidence interval=0.29-1.48) was found in the youngest group (15-19 years). The prevalences in the older age group did not change significantly. These findings show the early effects of HPV vaccination and confirm the effectiveness of immunization in a real-life setting.
引用
收藏
页码:340 / 342
页数:3
相关论文
共 50 条
[21]   Vaccination against human papillomavirus [J].
Aubin, F. .
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2012, 139 (05) :339-343
[22]   Human papillomavirus vaccination for boys [J].
Quinn, Stephany ;
Goldman, Ran D. .
CANADIAN FAMILY PHYSICIAN, 2015, 61 (01) :43-46
[23]   Vaccination against human papillomavirus [J].
Hillemanns, Peter ;
Kampers, Johanna ;
Hachenberg, Jens ;
Jentschke, Matthias .
INTERNIST, 2021, 62 (08) :816-826
[24]   Cost-effectiveness of human papillomavirus vaccination in Belgium: Do not forget about cervical cancer screening [J].
Thiry, Nancy ;
De Laet, Chris ;
Hulstaert, Frank ;
Neyt, Mattias ;
Huybrechts, Michel ;
Cleemput, Irina .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2009, 25 (02) :161-170
[25]   Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement [J].
Saslow, Debbie ;
Andrews, Kimberly S. ;
Manassaram-Baptiste, Deana ;
Loomer, Lacey ;
Lam, Kristina E. ;
Fisher-Borne, Marcie ;
Smith, Robert A. ;
Fontham, Elizabeth T. H. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (05) :375-385
[26]   A Behavioral Economic Approach to Improving Human Papillomavirus Vaccination [J].
Caskey, Rachel ;
Sherman, E. Grace ;
Beskin, Kera ;
Rapport, Rebecca ;
Xia, Yinglin ;
Schwartz, Alan .
JOURNAL OF ADOLESCENT HEALTH, 2017, 61 (06) :755-760
[27]   Barriers and Facilitators of Romanian HPV (Human Papillomavirus) Vaccination [J].
Manolescu, Loredana Sabina Cornelia ;
Zugravu, Corina ;
Zaharia, Corneliu Nicolae ;
Dumitrescu, Anca Irina ;
Prasacu, Irina ;
Radu, Mihaela Corina ;
Letitia, Goraneanu Draghici ;
Nita, Irina ;
Cristache, Corina Marilena ;
Gales, Laurentia Nicoleta .
VACCINES, 2022, 10 (10)
[28]   Young Hispanic Men and Human Papillomavirus Vaccination Choices [J].
Thomas, Tami L. ;
Stephens, Dionne P. ;
Johnson-Mallard, Versie ;
Higgins, Melinda .
JOURNAL OF TRANSCULTURAL NURSING, 2016, 27 (02) :103-108
[29]   Overall human papilloma virus and types 16/18 prevalence in women with normal cervical cytology in Serbia: is it time for human papillomavirus testing and/or vaccination? [J].
Malisic, Emina ;
Brotto, Ksenija ;
Krivokuca, Ana ;
Cavic, Milena ;
Jankovic, Radmila .
JOURNAL OF BUON, 2014, 19 (04) :973-979
[30]   Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in preadolescence in the Netherlands [J].
Sollie, Birgit ;
Berkhof, Johannes ;
Bogaards, Johannes A. .
BMC MEDICINE, 2025, 23 (01)